Literature DB >> 20823835

Carcinoid tumors of the gastrointestinal tract: trends in incidence in England since 1971.

Libby Ellis1, Matthew J Shale, Michel P Coleman.   

Abstract

OBJECTIVES: The epidemiology of gastrointestinal neuroendocrine tumors (GI-NETs) is poorly understood. Recent analyses have suggested changes in the incidence and distribution of such tumors, but have generally used data sets containing small patient numbers. We aimed to define trends in the epidemiology of GI-NETs in England over a 36-year period.
METHODS: We analyzed data from the national population-based cancer registry, which covers a population in excess of 50 million, over the period 1971-2006.
RESULTS: In all, 10,324 cases of GI-NETs were identified. The overall incidence increased from 0.27 (per 100,000 per year) to 1.32 for men and from 0.35 to 1.33 for women. The anatomic distribution of tumors in the latest period analyzed was stomach 12%, small intestine 29%, appendix 38%, colon 13%, and rectum 8%. The largest absolute increase in incidence was seen in the appendix (from 0.03 to 0.41 in men; from 0.05 to 0.59 in women). The greatest relative increase was in gastric NETs, increasing 2,325% in men, and 4,746% in women. Overall, 48% of GI-NETs occurred in men. Sex-specific incidence rates for gastric, colonic, and rectal NETs are similar, whereas appendiceal lesions were more common in females, and small intestinal tumors in men.
CONCLUSIONS: Large increases in the incidence of GI-NETs were observed, along with changes in anatomical distribution. Such changes may partly reflect changes in classification or improved detection through the increased use of endoscopy and imaging techniques. In view of the magnitude of these changes, particularly for gastric tumors, further studies to examine the underlying etiology of these changes are urgently indicated.

Entities:  

Mesh:

Year:  2010        PMID: 20823835     DOI: 10.1038/ajg.2010.341

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  74 in total

1.  Tumor size and depth predict rate of lymph node metastasis in colon carcinoids and can be used to select patients for endoscopic resection.

Authors:  Riad H Al Natour; Mandeep S Saund; Vivian M Sanchez; Edward E Whang; Ashish M Sharma; Qin Huang; Valia A Boosalis; Jason S Gold
Journal:  J Gastrointest Surg       Date:  2011-12-06       Impact factor: 3.452

2.  Do We Still Need to Perform Routine Histological Examination of Appendectomy Specimens?

Authors:  Salman Yousuf Guraya
Journal:  J Clin Diagn Res       Date:  2015-06-01

3.  Long-term follow up of endoscopic resection for type 3 gastric NET.

Authors:  Yong Hwan Kwon; Seong Woo Jeon; Gwang Ha Kim; Jin Il Kim; Il-Kwun Chung; Sam Ryong Jee; Heung Up Kim; Geom Seog Seo; Gwang Ho Baik; Kee Don Choi; Jeong Seop Moon
Journal:  World J Gastroenterol       Date:  2013-12-14       Impact factor: 5.742

Review 4.  Endoscopic diagnosis and management of type I neuroendocrine tumors.

Authors:  Yuichi Sato
Journal:  World J Gastrointest Endosc       Date:  2015-04-16

5.  IMP3 expression in small-intestine neuroendocrine neoplasms: a new predictor of recurrence.

Authors:  Sara Massironi; Alessandro Del Gobbo; Federica Cavalcoli; Stefano Fiori; Dario Conte; Alessio Pellegrinelli; Massimo Milione; Stefano Ferrero
Journal:  Endocrine       Date:  2017-02-17       Impact factor: 3.633

6.  Prevalence and clinicopathological characteristics of appendiceal carcinoids in Sharjah (United Arab Emirates).

Authors:  Khurshid Anwar; Munaf Desai; Noura Al-Bloushi; Farheen Alam; Farhan Sachal Cyprian
Journal:  World J Gastrointest Oncol       Date:  2014-07-15

7.  PROX1 is involved in progression of rectal neuroendocrine tumors, NETs.

Authors:  Juha Jernman; Pauliina Kallio; Jaana Hagström; Matti J Välimäki; Hannu Haapasalo; Kari Alitalo; Johanna Arola; Caj Haglund
Journal:  Virchows Arch       Date:  2015-06-11       Impact factor: 4.064

Review 8.  Management of gastric and duodenal neuroendocrine tumors.

Authors:  Yuichi Sato; Satoru Hashimoto; Ken-Ichi Mizuno; Manabu Takeuchi; Shuji Terai
Journal:  World J Gastroenterol       Date:  2016-08-14       Impact factor: 5.742

9.  Ki-67 is a reliable pathological grading marker for neuroendocrine tumors.

Authors:  Ashlie Nadler; Moises Cukier; Corwyn Rowsell; Sepideh Kamali; Yael Feinberg; Simron Singh; Calvin H L Law
Journal:  Virchows Arch       Date:  2013-04-16       Impact factor: 4.064

Review 10.  Neuroendocrine neoplasia of the gastrointestinal tract revisited: towards precision medicine.

Authors:  Guido Rindi; Bertram Wiedenmann
Journal:  Nat Rev Endocrinol       Date:  2020-08-24       Impact factor: 43.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.